What Does Syngene International Limited Do?

Total employees7392
HeadquartersBengaluru
Founded1993

Syngene International Ltd. is an innovation-focused global contract research, development, and manufacturing organization (CRDMO) providing integrated scientific services. Headquartered in Bengaluru, India, Syngene supports R&D programs from discovery to commercial supply for pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical companies worldwide. Their comprehensive service offerings include drug discovery and development, API manufacturing, biologics research and manufacturing, formulation development, and clinical development services, enabling clients to accelerate their R&D pipelines and bring innovative products to market efficiently.

Where Is Syngene International Limited's Headquarters?

Syngene International Limited officeSyngene International Limited officeSyngene International Limited officeSyngene International Limited office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Bengaluru headquarters is the nerve center for Syngene's global operations, housing advanced R&D laboratories, cGMP-compliant manufacturing plants for small and large molecules, and corporate functions. It facilitates end-to-end integrated service delivery.

Notable Features:

The campus features state-of-the-art R&D infrastructure, dedicated Centers of Excellence for various scientific disciplines, advanced analytical capabilities, commercial-scale biologics manufacturing, and a strong focus on safety, quality, and sustainability (e.g., green chemistry initiatives, high EHS standards).

Work Culture:

Syngene fosters a science-driven, collaborative, and client-centric work environment. The culture emphasizes quality, integrity, innovation, continuous learning, and employee development, attracting a diverse and highly skilled workforce.

HQ Significance:

The Bengaluru headquarters is strategically vital for Syngene's integrated ' molécule to market' service model. It centralizes diverse capabilities, enabling seamless project execution and leveraging India's scientific talent and cost-efficiencies for global clients.

Values Reflected in HQ: The headquarters' design, infrastructure, and operational standards reflect Syngene's core values of scientific excellence, integrity, quality, safety, customer focus, and innovation.

Location:

Syngene International Limited serves a diverse global clientele, including leading pharmaceutical, biotechnology, agrochemical, consumer health, animal health, and specialty chemical companies across North America, Europe, Japan, Australia, and other regions. While its core research, development, and manufacturing operations are strategically located in India (Bengaluru, Hyderabad, Mangaluru), Syngene maintains international business development offices in key markets such as the USA (Cambridge, MA) and the UK (Cheshire). This global network ensures localized client support, effective project management, and the ability to deliver integrated scientific solutions worldwide, contributing to innovation across multiple industries.

Street Address:

Biocon Park, Plot Nos 2 & 3, Bommasandra Phase IV, Jigani Link Road

City:

Bengaluru

State/Province:

Karnataka

Country:

India

Where Else Does Syngene International Limited Operate Around the World?

Hyderabad, Telangana, India

Address: Syngene International Limited, Plot No. 29, S.P. Biotech Park, Phase - III, Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District, Hyderabad – 500 101, Telangana, India

Serves as a significant R&D and services hub, complementing the Bengaluru operations and tapping into Hyderabad's rich pharmaceutical and biotech ecosystem.

Mangaluru, Karnataka, India

Address: Syngene International Ltd., Plot No. 1A & 1B, Mangalore Special Economic Zone (MSEZ), Bajpe, Mangaluru - 574 142, Karnataka, India

Acts as a key commercial manufacturing site, strategically located within an SEZ to facilitate export-oriented production and leverage port connectivity for efficient logistics.

Cambridge, Massachusetts, USA

Address: Syngene USA Inc., One Broadway, 14th Floor, Cambridge, MA 02142, USA

Strengthens Syngene's presence in the vital North American market, providing local support and fostering collaborations within one of the world's largest biotech clusters.

Macclesfield, Cheshire, UK

Address: Syngene Europe Limited, BioHub, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK

Enhances Syngene's footprint in the European market, allowing for closer collaboration with pharmaceutical companies, biotech firms, and research institutions across the UK and continental Europe.

Buying Intent Signals for Syngene International Limited

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Syngene International Limited? Meet the Executive Team

As of April 2025, Syngene International Limited' leadership includes:

Jonathan Hunt - Managing Director & Chief Executive Officer
Sibaji Biswas - Chief Financial Officer
Dr. Mahesh Bhalgat - Chief Operating Officer
Dr. Jan-Olav Henck - Senior Vice President - Discovery Services
Dr. Thomas Privette - Senior Vice President - Manufacturing Services
Dr. Joydeep Kant - Senior Vice President - Development Services
Vinita Shrivastava - Chief Human Resources Officer
Sanjeev Sukumaran - Chief Digital & Information Officer
Dr. Alex Trescec - Senior Vice President – Biologics
Priyadarshini Mahapatra - Company Secretary and Compliance Officer

Who's Investing in Syngene International Limited?

Syngene International Limited has been backed by several prominent investors over the years, including:

Biocon Limited (Promoter)
ICICI Prudential Mutual Fund
SBI Mutual Fund
HDFC Mutual Fund
Government Pension Fund Global (Norges Bank)
The Vanguard Group
BlackRock Inc.
Life Insurance Corporation of India

What Leadership Changes Has Syngene International Limited Seen Recently?

Hire1
Exits1

Over the last 12 months (May 2023 - May 2024), Syngene International Limited experienced a key leadership transition in its finance department with the appointment of a new Chief Financial Officer.

Departures

Sridhar Gorthi, Sridhar Gorthi resigned from his role as Chief Financial Officer. His last working day was December 17, 2023.

New Appointments:

Sibaji Biswas, Sibaji Biswas was appointed as the new Chief Financial Officer, taking charge from December 18, 2023. He has a strong background in financial leadership within various industries.

What Technology (Tech Stack) Is Used bySyngene International Limited?

Discover the tools Syngene International Limited uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Syngene International Limited Email Formats and Examples

Syngene International Limited typically uses a standard corporate email format. The most common patterns involve combinations of an employee's first name and last name, or first initial and last name, followed by the company domain '@syngeneintl.com'.

Common formats are [first].[last]@syngeneintl.com (e.g., john.doe@syngeneintl.com) and [first_initial][last]@syngeneintl.com (e.g., jdoe@syngeneintl.com).

Format

john.doe@syngeneintl.com

Example

70%

Success rate

What's the Latest News About Syngene International Limited?

Business StandardApril 24, 2024

Syngene International Q4 FY24 Net Profit Rises 6% to Rs 189 Crore

Syngene International reported a 6% year-on-year increase in its consolidated net profit to Rs 189 crore for the fourth quarter ended March 2024. The company's revenue from operations saw an 8% rise to Rs 917 crore, attributed to strong performance in its Development and Manufacturing services divisions....more

The Economic TimesNovember 28, 2023

Syngene International, Zumutor Biologics ink pact for antibody-drug conjugates development

Syngene International announced a strategic collaboration with US-based Zumutor Biologics Inc. The partnership aims to advance Zumutor's lead oncology molecule, ZM008, an antibody-drug conjugate (ADC), through integrated drug substance and drug product development, along with cGMP manufacturing....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Syngene International Limited, are just a search away.